In Alzheimer’s disease, evidence of the huge discrepancy in disease risk depending on APOE status, and the differential biological effects such as amyloid deposition and microglial activation make it likely that such interactions do exist. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.